Literature DB >> 15701726

Selective impairment of platelet activation to collagen in the absence of GATA1.

Sascha C Hughan1, Yotis Senis, Denise Best, Angela Thomas, Jon Frampton, Paresh Vyas, Steve P Watson.   

Abstract

Defects in the X-linked DNA-binding megakaryocyte transcription factor GATA1 cause thrombocytopenia and abnormal platelet function. However, detailed studies of GATA1 function in platelet activation are lacking. Here, we studied platelets from GATA1-deficient mice and from a male patient (S14) with a bleeding diathesis attributed to a single amino acid substitution (R216Q) in the N-terminal GATA1 zinc finger that alters binding to DNA. In both cases there was inhibition of aggregation to collagen and decreased tyrosine phosphorylation of glycoprotein VI (GPVI)-signaling proteins. This effect was more marked in GATA1-deficient murine platelets, where it was associated with a significant reduction in surface GPVI expression. Moreover, both human and murine GATA1-mutant platelets showed reduced adhesion and aggregate formation on a collagen matrix at an intermediate rate of shear, although this could not be accounted solely by the thrombocytopenia and altered GPVI expression, indicating that GATA1 regulates additional factors important for platelet activation under shear. In contrast, there was no inhibition of responses to G protein-coupled receptor agonists in GATA1-perturbed platelets. Our results are consistent with GATA1 regulating some but not all pathways of platelet activation, leading to an impairment of aggregate formation under flow, which cannot be attributed solely to the thrombocytopenia.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15701726     DOI: 10.1182/blood-2004-10-4098

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Pleiotropic platelet defects in mice with disrupted FOG1-NuRD interaction.

Authors:  Yuhuan Wang; Ronghua Meng; Vincent Hayes; Rudy Fuentes; Xiang Yu; Charles S Abrams; Harry F G Heijnen; Gerd A Blobel; Michael S Marks; Mortimer Poncz
Journal:  Blood       Date:  2011-10-11       Impact factor: 22.113

Review 2.  Hematopoietic transcription factor mutations: important players in inherited platelet defects.

Authors:  Natthapol Songdej; A Koneti Rao
Journal:  Blood       Date:  2017-04-17       Impact factor: 22.113

Review 3.  Inherited platelet dysfunction and hematopoietic transcription factor mutations.

Authors:  Natthapol Songdej; A Koneti Rao
Journal:  Platelets       Date:  2016-07-27       Impact factor: 3.862

4.  Human phenotypes associated with GATA-1 mutations.

Authors:  Wendy A Ciovacco; Wendy H Raskind; Melissa A Kacena
Journal:  Gene       Date:  2008-09-30       Impact factor: 3.688

Review 5.  GATA1 mutations in red cell disorders.

Authors:  Te Ling; John D Crispino
Journal:  IUBMB Life       Date:  2019-10-25       Impact factor: 3.885

Review 6.  Hematopoietic transcription factor mutations and inherited platelet dysfunction.

Authors:  Natthapol Songdej; A Koneti Rao
Journal:  F1000Prime Rep       Date:  2015-05-26

7.  Repercussion of Megakaryocyte-Specific Gata1 Loss on Megakaryopoiesis and the Hematopoietic Precursor Compartment.

Authors:  Marjolein Meinders; Mark Hoogenboezem; Maaike R Scheenstra; Iris M De Cuyper; Petros Papadopoulos; Tamás Németh; Attila Mócsai; Timo K van den Berg; Taco W Kuijpers; Laura Gutiérrez
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

8.  Prognostic significance of mutated genes in megakaryocytic disorders.

Authors:  Ali Amin Asnafi; Mohammad Bagher Mohammadi; Hadi Rezaeeyan; Nader Davari; Najmaldin Saki
Journal:  Oncol Rev       Date:  2019-07-22

9.  Novel GATA1 Variant Causing a Bleeding Phenotype Associated with Combined Platelet α-/δ-Storage Pool Deficiency and Mild Dyserythropoiesis Modified by a SLC4A1 Variant.

Authors:  Kerstin Jurk; Anke Adenaeuer; Stefanie Sollfrank; Kathrin Groß; Friederike Häuser; Andreas Czwalinna; Josef Erkel; Nele Fritsch; Dana Marandiuc; Martin Schaller; Karl J Lackner; Heidi Rossmann; Frauke Bergmann
Journal:  Cells       Date:  2022-09-29       Impact factor: 7.666

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.